BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10402561)

  • 1. Fatty acid anilides: in vivo formation and relevance to toxic oil syndrome.
    Kaphalia BS; Khan MF; Ansari GA
    J Biochem Mol Toxicol; 1999; 13(5):269-77. PubMed ID: 10402561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC-MS ion maps for the characterization of aniline derivatives of fatty acids and triglycerides in laboratory-denatured rapeseed oil.
    Reig N; Calaf RE; Messeguer A; Morató A; Escabros J; Gelpí E; Abian J
    J Mass Spectrom; 2007 Apr; 42(4):527-41. PubMed ID: 17295417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid ethyl and methyl ester synthases, and fatty acid anilide synthase in HepG2 and AR42J cells: interrelationships and inhibition by tri-o-tolyl phosphate.
    Kaphalia BS; Green SM; Ansari GA
    Toxicol Appl Pharmacol; 1999 Sep; 159(2):134-41. PubMed ID: 10495777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible etiologic agents for toxic oil syndrome: fatty acid esters of 3-(N-phenylamino)-1,2-propanediol.
    Hill RH; Schurz HH; Posada de la Paz M; Abaitua Borda I; Philen RM; Kilbourne EM; Head SL; Bailey SL; Driskell WJ; Barr JR
    Arch Environ Contam Toxicol; 1995 Feb; 28(2):259-64. PubMed ID: 7710294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential implication of aniline derivatives in the Toxic Oil Syndrome (TOS).
    Messeguer A
    Chem Biol Interact; 2011 Jun; 192(1-2):136-41. PubMed ID: 20970410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Storage time and deodorization temperature influence the formation of aniline-derived compounds in denatured rapeseed oils.
    Ruiz-Méndez MV; Posada de la Paz M; Abian J; Calaf RE; Blount B; Castro-Molero N; Philen R; Gelpí E
    Food Chem Toxicol; 2001 Jan; 39(1):91-6. PubMed ID: 11259855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the generation and outcome of 3-(N-phenylamino)propane-1,2-diol derivatives in deodorized model oils related to toxic oil syndrome.
    Morató A; Escabrós J; Manich A; Reig N; Castaño Y; Abián J; Messeguer A
    Chem Res Toxicol; 2005 Apr; 18(4):665-74. PubMed ID: 15833026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome.
    Mayeno AN; Benson LM; Naylor S; Colberg-Beers M; Puchalski JT; Gleich GJ
    Chem Res Toxicol; 1995; 8(7):911-6. PubMed ID: 8555405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin and autoantibody responses in MRL/lpr mice treated with 'toxic oils'.
    Koller LD; Stang BV; Hall JA; Posada de la Paz M; Ruiz Mendez MV
    Toxicology; 2002 Sep; 178(2):119-33. PubMed ID: 12160619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of c-fos messenger RNA by 3-(N-phenylamino)-1,2-propanediol esters, compounds related to Toxic Oil Syndrome.
    Serrano-Mollar A; Fernández-Zabalegui L; Bulbena O; Gelpí E; Closa D
    Chem Biol Interact; 2004 Oct; 149(2-3):117-23. PubMed ID: 15501433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic oil syndrome: traceback of the toxic oil and evidence for a point source epidemic.
    Posada de la Paz M; Philen RM; Borda IA; Sicilia Socias JM; Gómez de la Cámara A; Kilbourne EM
    Food Chem Toxicol; 1996 Mar; 34(3):251-7. PubMed ID: 8621106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption and effects of 3-(N-phenylamino)-1,2-propanediol esters in relation to toxic oil syndrome.
    Closa D; Folch E; Calaf RE; Abián J; Roselló-Catafau J; Gelpí E
    Lipids; 2001 Oct; 36(10):1125-33. PubMed ID: 11768157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
    Kilbourne EM; Bernert JT; Posada de la Paz M; Hill RH; Abaitua Borda I; Kilbourne BW; Zack MM
    Am J Epidemiol; 1988 Jun; 127(6):1210-27. PubMed ID: 3369420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Products of aniline and triglycerides in oil samples associated with the toxic oil syndrome.
    Schurz HH; Hill RH; Posada de la Paz M; Philen RM; Borda IA; Bailey SL; Needham LL
    Chem Res Toxicol; 1996 Sep; 9(6):1001-6. PubMed ID: 8870988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic vascular toxicity and fatty acid anilides in the toxic oil syndrome.
    Boor PJ; Khan MF; Kaphalia BS; Jerrells TR; Ansari GA
    J Am Coll Cardiol; 1991 Dec; 18(7):1824-8. PubMed ID: 1960335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gas chromatographic/mass spectrometric determination of aniline in food oils associated with the Spanish toxic oil syndrome.
    Hill RH; Todd GD; Kilbourne EM; Cline RE; McCraw J; Orti DL; Bailey SL; Needham LL
    Bull Environ Contam Toxicol; 1987 Sep; 39(3):511-5. PubMed ID: 3664006
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological basis of toxic oil syndrome (TOS).
    Gallardo S; del Pozo V; Cárdaba B; de Andrés B; Martín-Orozco E; Fernandez JC; Tramón P; Posada M; Abaitua I; Palomino P
    Toxicology; 1994 Nov; 93(2-3):289-99. PubMed ID: 7974520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of aniline derivatives in oils related to the toxic oil syndrome by atmospheric pressure ionization-tandem mass spectrometry.
    Calaf RE; Peña J; Paytubi S; Blount BC; Posada de la Paz M; Gelpi E; Abian J
    Anal Chem; 2001 Aug; 73(16):3828-37. PubMed ID: 11534704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
    Posada de la Paz M; Philen RM; Abaitua Borda I; Diez Ruiz-Navarro M; Abraira Santos V; Pozo Rodríguez F; Pla Mestre R; Pollán Santamaría M; Sicilia Socias JM; Azpeitia Gamazo P
    Epidemiology; 1994 Jul; 5(4):404-9. PubMed ID: 7918809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipid fatty acid and lipid peroxidation in liver microsomes from guinea pigs fed oil related to the toxic oil syndrome.
    Arévalo JC; Pérez-González MN; Sánchez-Bernal C; Llanillo M
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1998 Jul; 120(1):111-9. PubMed ID: 9827023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.